Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China
Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. π𧬠She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. π She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. π Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. π§ π A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. π𧫠Dr. Huβs commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. ππ₯
Publication Profile
Orcid
Education
Dr. Yongfang Huβs academic journey began with a Bachelorβs Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). ππ She further pursued a Masterβs Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. π¬π To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). π§¬π Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. π§ π§ͺ Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. π
π
Experience
From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. π₯π She later joined Peking University Third Hospital (2005β2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. π§ͺπ Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. π§¬π₯ Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. π‘π
Awards and Honors
Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. π In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. ποΈ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. ππ©ββοΈ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. π§¬π These honors signify her continuous impact on both patient care and the broader medical research landscape. π§ π
Research Focus
Dr. Huβs research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. π§¬π« She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. π§ π She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. π§«π‘οΈ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. π΅β€οΈ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. ππ Her interdisciplinary approach bridges pharmacology, genomics, and patient care. ππ
Publication Top Notes
Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study π§«π§¬